PTC 2021 Corporate Deck Updated Nov 30, 2021 PTC Forward Looking Statements 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 199 5. All statements contained in this release, other than statements of historic fact, are forward -looking statements, including statements with respect to 2021 net p roduct revenue guidance, statements with respect to the 2021 operating expenditure guidance and statements regarding: the future expectation ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2021 Earnings Conference Call October 28, 2021 4:30 PM ET Company Participants Kylie O'Keefe – Head-Investor Relations Stuart Peltz – Chief Executive Officer Matthew Klein – Chief Development Officer Eric Pauwels – Chief Business Officer Emily Hill – Chief Financial Officer Conference Call Participants Danielle Brill – Raymond James Tazeen Ahmad – Bank of America Raju Prasad – William Blair Brian Abrahams – RBC Capital Markets Peyton Bohnsack – Cowen and Company Kripa ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35969 PTC Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 04-3416587 ( ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2021 Earnings Conference Call July 29, 2021 4:30 PM ET Company Participants Kylie O'Keefe - Senior Vice President, Global Commercial and Corporate Strategy Stuart Peltz - Chief Executive Officer Matthew Klein - Chief Development Officer Eric Pauwels - Chief Business Officer Emily Hill - Chief Financial Officer Conference Call Participants Eric Joseph - JPMorgan Nina Daniels - Cantor Fitzgerald Tazeen Ahmad - Bank of America Peyton Bohnsack - Cowen Alex Sklar - Raymond ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant t ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2021 Results Conference Call May 4, 2021 4:30 PM ET Company Participants Kylie O'Keefe - Senior Vice President Commercial and Corporate Strategy Stuart Peltz - Chief Executive Officer Matthew Klein - Chief Development Officer Eric Pauwels - Chief Business Officer Emily Hill - Chief Financial Officer Conference Call Participants Eric Joseph - JP Morgan Robyn Karnauskas - Truist Securities Brian Abrahams - RBC Capital Markets Joseph Thome - Cowen & Company Colin Bristow ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35969 PTC Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 04-3416587 (Stat ...

PTC518 Huntington's Disease Deep Dive April 15th, 2021 PTC) Forward Looking Statements: This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this release, other than statements of historic fact, are forward-looking statements, including statements with respect to the future expectations, plans and prospects for PTC, PTC's strategy, including with respect to the expected timing of clinical trials and stud ...

Call Start: 16:30 January 1, 0000 5:52 PM ET PTC Therapeutics, Inc (NASDAQ:PTCT) Q4 2020 Earnings Conference Call February 25, 2021 16:30 PM ET Company Participants Kylie O'Keefe - Head of Investor Relations Stuart Peltz - Founder and Chief Executive Officer Emily Hill - Chief Financial Officer Eric Pauwels - Chief Business Officer Matthew Klein - Chief Development Officer Conference Call Participants Eric Joseph - JPmorgan Li Watsek - Cantor Fitzgerald & Co Minh Vong - Truist Securities Joel Beatty - Citi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-35969 PTC THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3416587 (State or other jurisdiction of incorporati ...